Evidence map›Paper›PMID 33994716›Full record

ArticleJournal of clinical and experimental hepatology

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.

Edmondo Falleti, Sara Cmet, Anna R Cussigh, Elena Salvador, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, Carlo Fabris, Pierluigi Toniutto

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Overview of Complications in Cirrhosis.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Edmondo FalletiClinical Pathology, Laboratory Medicine, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Sara CmetClinical Pathology, Laboratory Medicine, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Anna R CussighClinical Pathology, Laboratory Medicine, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Elena SalvadorClinical Pathology, Laboratory Medicine, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Davide BitettoHepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Ezio FornasiereHepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Elisa FumoloHepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Carlo FabrisHepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Pierluigi ToniuttoHepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
Azienda Sanitaria Universitaria Integrata di Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis. However, the incidence and the real impact of SBP in determining patient survival rates remain unclear. This study aims to evaluate the incidence and risk factors for SBP development and the role of SBP in predicting transplant-free survival.

methodsTwo hundred two consecutive patients underwent 492 paracenteses with biochemical and microbiological analysis of the ascitic fluid. When multiple paracenteses had been performed on a given patient, the first SBP-positive paracentesis or the first paracentesis conducted when none was diagnostic for SBP was included in the study.

resultsSBP was detected in 28 of 202 (13.9%) patients; in 26 of 28 patients, the neutrophil count in the ascitic fluid was ≥250 cells/μl, and in 15 of 28 patients, the cultures were positive. Variables independently associated with SBP were as follows: a higher model of end-stage liver disease (MELD) score, the serum glucose value, elevated CRP serum levels, and higher potassium serum levels. Overall, the median (range) transplant-free survival was 289 (54-1253) days. One hundred (49.5%) patients died, whereas 35 patients (17.3%) underwent liver transplantation. Independent predictors of death or liver transplantation were a higher MELD score and the development of SBP, especially if it was antibiotic-resistant or recurrent SBP.

conclusionThe occurrence of SBP is associated with more severe liver dysfunction in conjunction with the presence of inflammation. Unlike the occurrence of SBP

Indexed as

ALP, alkaline phosphataseALT, alanine aminotransferaseantibiotic-resistant infectionsascitesAST, aspartate aminotransferaseBMI, body mass indexCLIF-SOFA, chronic liver failure-sequential organ failure assessmentCP, Child-PughCRP, C-reactive proteinEPS, hepatic encephalopathygGT, gamma-glutamyl transpeptidaseHBV, hepatitis B virusHCV, hepatitis C virusINR, international normalized ratioliver transplantationLT, liver transplantationMELD, model of end-stage liver diseaseOR, odds ratioPLT, plateletSBP, Spontaneous bacterial peritonitisSIRS, systemic inflammatory response syndromesurvivalWBC, white blood cell

Identifiers

PMID33994716
PMCPMC8103328
OpenAlexW3083451326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.